一种非侵入性BCG皮肤挑战模型,用于评估结核病疫苗的疗效
Nitya Krishnan1, Miles Priestman1, Iria Uhía1
1Department of Infectious Disease, Imperial College London, London, United Kingdom.
PLoS biology
|August 19, 2024
概括
使用光 Calmette-Guérin (BCG) 的新型非侵入性小鼠模型评估结核病 (TB) 疫苗的疗效. 接种BCG疫苗可以降低细菌负载,这表明它是开发结核病疫苗的有希望的工具.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 控制的人类感染模型 (CHIM) 对疫苗开发至关重要,但与Mycobacterium结核病 (Mtb) 面临挑战.
- 一个更安全的替代方案是使用减弱的Mycobacterium bovis Bacille Calmette-Guérin (BCG) 作为代用和皮内挑战.
- 为了动态评估疫苗反应,需要进行非侵入性成像.
研究的目的:
- 在小鼠的非侵入性BCG皮肤挑战模型中进行结核病 (TB) 疫苗疗效评估.
- 评估模型使用光报告器量化测量细菌负载的能力.
- 为了比较获得许可的BCG和新型亚单元候选疫苗的有效性.
主要方法:
- 使用光BCG (FluorBCG) 开发一种非侵入性成像系统,用于定量细菌负载测量.
- 使用非线性混合效应模型来分析随着时间的推移的光衰减.
- 通过比较接种疫苗和未接种疫苗的小鼠的光读数来评估疫苗的疗效.
主要成果:
- 与未接种疫苗的小鼠相比,BCG疫苗接种显著降低了光读数 (p < 0.001).
- 新型亚单元候选疫苗没有显著改变光衰减 (p > 0.05).
- 降低光度的BCG疫苗接种小鼠在MTB挑战时也显示出肺部细菌负担降低.
结论:
- 非侵入性BCG皮肤挑战模型有效测量结核病疫苗的有效性.
- 皮肤中的光活性与功能性肺免疫反应相关.
- 该模型提供了一种动态的,非侵入性的方法来评估结核病疫苗候选人.
相关概念视频
01:26Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
01:31Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316